ARCHIVES

In a letter, ASCO reaffirms its views on oncology consolidation at FDA.

This article is from The Cancer Letter archive.

Vol. 30 No. 28 | July 9, 2004

Download PDF Visit The Full Archive

Related Articles

Fisher Seeks Damages Under Privacy Act; NIH Consents To Remove Database Flags

March 10, 1995

Updated EMILIA Phase III Trial Results Confirm Increase in Overall Survival

August 31, 2012

IG Report Clears Shubik Of Conflict Of Interest Change

October 6, 1978

Radiation Oncologist Objects To ACR Comments Results

November 27, 1981

Adverse Events Of Chemo More Common Than Expected

August 25, 2006

Amgen Replaces “Bundling” Contract With Three Separate Contracts For Growth Factors.

September 5, 2008